Aktieanalys

NextCell Pharma: All patients treated in the ProTrans V study - Redeye

{newsItem.title}

Redeye Publicerad: 20 Feb 15:29

NextCell Pharma

Redeye leaves a short comment on yesterday's announcement that all patients in the ProTrans V study have been treated.

Länk till analysen i sin helhet: https://www.redeye.se/research/1080593/nextcell-pharma-all-patients-treated-in-the-protrans-v-study?utm_source=finwire&utm_medium=RSS

Nyheter om NextCell Pharma

Läses av andra just nu

Om aktien NextCell Pharma

Senaste nytt